Cover Image
市場調查報告書

臨床試驗用品的全球市場預測 2020年:物流 & 流通、製造、包裝、標籤

Clinical Trial Supplies Market by Products & Services (Logistics & Distribution, Manufacturing, Packaging & Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020

出版商 MarketsandMarkets 商品編碼 341701
出版日期 內容資訊 英文 134 Pages
訂單完成後即時交付
價格
Back to Top
臨床試驗用品的全球市場預測 2020年:物流 & 流通、製造、包裝、標籤 Clinical Trial Supplies Market by Products & Services (Logistics & Distribution, Manufacturing, Packaging & Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020
出版日期: 2015年10月06日 內容資訊: 英文 134 Pages
簡介

全球臨床試驗用品市場預計從2015年的9億340萬美元到2020年達到12億7,430萬美元。

本報告提供全球臨床試驗用品市場相關調查、市場規模的變化與預測、各產品與服務、階段、產品、治療領域及地區的明細、競爭情形,及主要企業簡介等、詳細內容彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 臨床試驗用品市場
  • 臨床試驗用品市場佔有率:服務 vs. 地區
  • 地區分析:臨床試驗用品市場,各階段
  • 地區分析:臨床試驗用品市場,各產品
  • 生命週期分析:地區

第5章 市場概要

  • 簡介
  • 臨床試驗用品:市場區隔
    • 各產品與服務
    • 各階段
    • 各治療領域
    • 各地區
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
  • 緊急的課題

第6章 臨床試驗用品市場:產品與服務

  • 簡介
  • 製造
  • 包裝、標籤
  • 物流、流通

第7章 臨床試驗用品市場:各階段

  • 簡介
  • 階段I
  • 階段II
  • 階段III、生物學同等性的研究

第8章 臨床試驗用品市場:各治療領域

  • 簡介
  • 癌症
  • CNS、性心臟疾病
  • 心血管疾病
  • 感染疾病
  • 呼吸疾病
  • 血液疾病
  • 皮膚

第9章 臨床試驗用品市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他 (ROW )

第10章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢

第11章 企業介紹

  • 簡介
  • ALMAC GROUP LTD,
  • CATALENT PHARMA SOLUTIONS, INC. 1
  • PAREXEL INTERNATIONAL
  • THERMO FISHER SCIENTIFIC, INC.
  • PCI SERVICES
  • PATHEON, INC.
  • SHARP PACKAGING SERVICES
  • BIOCAIR
  • MOVIANTO
  • KLIFO A/S

第12章 附錄

圖表清單

目錄
Product Code: PH 3772

The clinical trial supplies market is expected to reach USD 1,274.3 million by 2020 from USD 904.3 million in 2015, at a CAGR of 7.1%. The global clinical trial supplies market is segmented based on products and services, phases, therapeutic areas, and regions. The logistics and distribution services segment is expected to register the highest growth rate in the clinical trial supplies market, by products and services, during the forecast period. The high growth in this segment is attributed to the globalization of clinical trials and increasing outsourcing services.

The major factors contributing to the growth of the clinical trial supplies market include globalization of clinical trial activities, increasing R&D investments and government support, and rising incidences of various diseases. Furthermore, increasing expansion activities by CROs is another major factor driving the growth of this market.

For instance, in October 2014, Almac expanded its U.K. commercial packaging facility with a significant investment to meet the requirement of Japanese clients. The expansion included an extensive suite of modifications for processing humidity-sensitive drug products; the installation of a new Noack 623 blister line; a custom designed desiccant feeder; and an off-line Hapa Blister-Jet printer. Increasing patent expiry and development of generic drugs and high growth potential in emerging markets has opened an array of opportunities for the clinical trial supplies market. However, factors such as longer approval times for clinical trials are hampering the growth of the market to a certain extent.

Apart from comprehensive geographic and product/service analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding service offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product/service portfolios of the top players in the clinical trial supplies market. The report analyzes the clinical trial supplies market by products and services, phases, therapeutic areas, and regions
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the clinical trial supplies market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the clinical trial supplies market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various clinical trial supplies market services and products across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the clinical trial supplies market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKET SEGMENTATION
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. KEY INDUSTRY INSIGHTS
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CLINICAL TRIAL SUPPLIES MARKET
  • 4.2. CLINICAL TRIAL SUPPLIES MARKET SHARE, SERVICES VS. REGIONS
  • 4.3. GEOGRAPHIC ANALYSIS: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE
  • 4.4. GEOGRAPHIC ANALYSIS: CLINICAL TRIAL SUPPLIES MARKET, BY PRODUCT
  • 4.5. LIFECYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. CLINICAL TRIAL SUPPLIES: MARKET SEGMENTATION
    • 5.2.1. BY PRODUCTS AND SERVICES
    • 5.2.2. BY PHASE
    • 5.2.3. BY THERAPEUTIC AREA
    • 5.2.4. BY REGION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. MARKET DRIVERS
      • 5.3.1.1. Globalization of clinical trial activities
      • 5.3.1.2. Increasing R&D investments and government support
      • 5.3.1.3. Rising incidences of various diseases
      • 5.3.1.4. Increasing expansion activities by CROs
    • 5.3.2. MARKET RESTRAINS
      • 5.3.2.1. Longer approval times for clinical trials
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Emerging markets
      • 5.3.3.2. Increasing number of patent expirations and development of generic drugs
  • 5.4. INDUSTRY TRENDS
    • 5.4.1. JUST-IN-TIME PACKAGING AND LABELING METHODS FOR CLINICAL TRIAL SUPPLIES

6. CLINICAL TRIAL SUPPLIES MARKET, BY PRODUCT AND SERVICE

  • 6.1. INTRODUCTION
  • 6.2. MANUFACTURING
  • 6.3. PACKAGING AND LABELING
  • 6.4. LOGISTICS AND DISTRIBUTION

7. CLINICAL TRIAL SUPPLIES MARKET, BY PHASE

  • 7.1. INTRODUCTION
  • 7.2. PHASE I
  • 7.3. PHASE II
  • 7.4. PHASE III AND BIOEQUIVALENCE STUDIES

8. CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA

  • 8.1. INTRODUCTION
  • 8.2. ONCOLOGY
  • 8.3. CNS AND MENTAL DISORDERS
  • 8.4. CARDIOVASCULAR DISEASES
  • 8.5. INFECTIOUS DISEASES
  • 8.6. RESPIRATORY DISEASES
  • 8.7. BLOOD DISORDERS
  • 8.8. DERMATOLOGY
  • 8.9. OTHERS

9. CLINICAL TRIAL SUPPLIES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. U.K.
    • 9.3.2. GERMANY
    • 9.3.3. FRANCE
    • 9.3.4. SPAIN
    • 9.3.5. ITALY
    • 9.3.6. REST OF EUROPE (ROE)
  • 9.4. ASIA-PACIFIC
    • 9.4.1. CHINA
    • 9.4.2. INDIA
    • 9.4.3. JAPAN
    • 9.4.4. REST OF ASIA-PACIFIC (ROAPAC)
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATIONS AND TRENDS
    • 10.3.1. EXPANSION
    • 10.3.2. AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURE
    • 10.3.3. ACQUISITIONS
    • 10.3.4. NEW PRODUCT AND SERVICE LAUNCHES
    • 10.3.5. OTHERS

11. COMPANY PROFILES (Overview, Financials, Products & Services, and Developments)*

  • 11.1. INTRODUCTION
  • 11.2. ALMAC GROUP LTD,
  • 11.3. CATALENT PHARMA SOLUTIONS, INC.
  • 11.4. PAREXEL INTERNATIONAL
  • 11.5. THERMO FISHER SCIENTIFIC, INC.
  • 11.6. PCI SERVICES
  • 11.7. PATHEON, INC.
  • 11.8. SHARP PACKAGING SERVICES
  • 11.9. BIOCAIR
  • 11.10. MOVIANTO
  • 11.11. KLIFO A/S.

*Details on overview, financials, product & services, and developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: INCREASING EXPANSION ACTIVITIES BY CROS TO BOOST THE MARKET GROWTH FOR CLINICAL TRIAL SUPPLIES
  • TABLE 2: LONGER APPROVAL TIMES FOR CLINICAL TRIALS ARE RESTRAINING THE GROWTH OF THE MARKET
  • TABLE 3: GROWTH PROSPECTS IN EMERGING COUNTRIES TO FUEL THE MARKET GROWTH
  • TABLE 4: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT AND SERVICE, 2013-2020 (USD MILLION)
  • TABLE 5: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 6: NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 7: EUROPE: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 8: ASIA-PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 9: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR MANUFACTURING SERVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR MANUFACTURING SERVICES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 11: EUROPE: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR MANUFACTURING SERVICES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 12: ASIA-PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR MANUFACTURING SERVICES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 13: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PACKAGING AND LABELING SERVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PACKAGING AND LABELING SERVICES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 15: EUROPE: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PACKAGING AND LABELING SERVICES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 16: ASIA-PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PACKAGING AND LABELING SERVICES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 17: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR LOGISTICS AND DISTRIBUTION SERVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR LOGISTICS AND DISTRIBUTION SERVICES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 19: EUROPE: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR LOGISTICS AND DISTRIBUTION SERVICES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 20: ASIA-PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR LOGISTICS AND DISTRIBUTION SERVICES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 21: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2013-2020 (USD MILLION)
  • TABLE 22: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 24: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PHASE I TRIALS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PHASE I TRIALS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 26: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PHASE II TRIALS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PHASE II TRIALS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 28: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PHASE III TRIALS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PHASE III TRIALS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 30: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 31: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 32: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR ONCOLOGY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR CNS AND MENTAL DISORDERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR CARDIOVASCULAR DISEASES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR INFECTIOUS DISEASES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR RESPIRATORY DISEASES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 37: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR BLOOD DISORDERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 38: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR DERMATOLOGY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 39: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 40: NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 41: NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2013-2020 (USD MILLION)
  • TABLE 42: NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 43: U.S.: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 44: U.S.: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2013-2020 (USD MILLION)
  • TABLE 45: CANADA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 46: CANADA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2013-2020 (USD MILLION)
  • TABLE 47: EUROPE: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 48: EUROPE: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2013-2020 (USD MILLION)
  • TABLE 49: EUROPE: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 50: U.K.: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 51: GERMANY: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 52: FRANCE: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 53: SPAIN: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 54: ITALY: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 55: ROE: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 56: ASIA-PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 57: ASIA-PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2013-2020 (USD MILLION)
  • TABLE 58: ASIA-PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 59: CHINA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 60: INDIA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 61: JAPAN: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 62: ROAPAC: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 63: ROW: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 64: ROW: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2013-2020 (USD MILLION)
  • TABLE 65: ROW: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 66: EXPANSIONS, 2012-2015
  • TABLE 67: AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURE, 2012-2015
  • TABLE 68: ACQUISITIONS, 2012-2015
  • TABLE 69: NEW PRODUCT AND SERVICE LAUNCHES, 2012-2015
  • TABLE 70: OTHERS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: CLINICAL TRIAL SUPPLIES MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: TOP-DOWN APPROACH
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, & REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: CLINICAL TRIAL PRODUCTS AND SERVICES MARKET SNAPSHOT, 2015 VS. 2020
  • FIGURE 8: NORTH AMERICA TO DOMINATE THE LOGISTICS AND DISTRIBUTION MARKET FROM 2015 TO 2020
  • FIGURE 9: ONCOLOGY SEGMENT TO COMMAND THE LARGEST MARKET SHARE AND IS EXPECTED TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 10: PHASE III TO DOMINATE THE CLINICAL TRIAL SUPPLIES MARKET FROM 2015 TO 2020
  • FIGURE 11: CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2015
  • FIGURE 12: ASIA-PACIFIC REGION TO WITNESS HIGHEST GROWTH RATE IN THE CLINICAL TRIAL SUPPLIES MARKET FROM 2015 TO 2020
  • FIGURE 13: CLINICAL TRIAL SUPPLIES MARKET TO SHOWCASE LUCRATIVE GROWTH OPPORTUNITIES IN THE FORECAST PERIOD
  • FIGURE 14: LOGISTICS AND DISTRIBUTION SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015
  • FIGURE 15: PHASE III SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 16: LOGISTICS AND DISTRIBUTION WILL CONTINUE TO LEAD THE MARKET IN THE FORECAST PERIOD
  • FIGURE 17: ASIA-PACIFIC MARKET FOR CLINICAL TRIAL SUPPLIES TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 18: CLINICAL TRIAL SUPPLIES MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 19: LOGISTICS AND DISTRIBUTION SERVICES SEGMENT EXPECTED TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 20: NORTH AMERICA EXPECTED TO DOMINATE THE MARKET FOR MANUFACTURING SERVICES IN THE FORECAST PERIOD
  • FIGURE 21: PHASE III SEGMENT IS EXPECTED TO DOMINATE THE MARKET IN THE FORECAST PERIOD
  • FIGURE 22: ONCOLOGY SEGMENT DOMINATES THE CLINICAL TRIAL SUPPLIES MARKET IN 2015
  • FIGURE 23: NORTH AMERICA DOMINATES THE ONCOLOGY MARKET IN 2015
  • FIGURE 24: GEOGRAPHIC SNAPSHOT: EMERGING MARKETS HOLD SIGNIFICANT GROWTH OPPORTUNITIES IN THE FORECAST PERIOD
  • FIGURE 25: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 26: PHASE III SEGMENT WILL DRIVE THE GROWTH OF THE CLINICAL TRIAL SUPPLIES MARKET IN THE U.S. IN THE FORECAST PERIOD
  • FIGURE 27: GERMANY IS PROJECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 28: ASIA-PACIFIC: MARKET SNAPSHOT
  • FIGURE 29: EXPANSION WAS THE MAJOR STRATEGY ADOPTED BETWEEN 2012 AND 2015
  • FIGURE 30: GLOBAL CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 31: BATTLE FOR MARKET SHARE: EXPANSION, THE MOST ACTIVELY ADOPTED STRATEGY BY MARKET PLAYERS
  • FIGURE 32: PRODUCT BENCHMARKING FOR MAJOR PLAYERS
  • FIGURE 33: CATALENT PHARMA SOLUTIONS, INC.: COMPANY SNAPSHOT
  • FIGURE 34: PAREXEL INTERNATIONAL: COMPANY SNAPSHOT
  • FIGURE 35: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 36: SHARP PACKAGING SERVICES: COMPANY SNAPSHOT
Back to Top